Literature DB >> 18410428

The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study.

Takashige Abe1, Nobuo Shinohara, Toru Harabayashi, Ataru Sazawa, Shuhei Ishikawa, Kanako Kubota, Yoshihiro Matsuno, Takahiro Osawa, Takeshi Shibata, Yuichiro Shinno, Shinji Kamota, Keita Minami, Shigeo Sakashita, Ichiro Takeuchi, Akira Kumagai, Tatsuya Mori, Masaki Togashi, Katsuya Nonomura.   

Abstract

OBJECTIVES: To determine the role of lymph-node (LN) dissection in patients undergoing surgery for upper urinary tract (UUT) cancer. PATIENTS AND METHODS: We reviewed the clinicopathological data from 312 patients with UUT cancer treated predominantly by nephroureterectomy. The relationship between clinical characteristics and cancer-specific survival (CSS) was analysed, focusing on node-related information.
RESULTS: In all, 166 patients had LN dissection while 146 did not (pNx). Multivariate analysis showed that T stage, grade and pN status were significant variables for CSS. The difference in survival between the pN0 and pNx groups remained significant in a multivariate analysis. The median (range) number of LNs removed was 6 (1-65). There was no significant difference in CSS between the 72 patients with fewer than six LNs removed and the 78 with six or more removed.
CONCLUSIONS: LN dissection is important for postoperative stratification of patients with UUT cancer because node-positive disease was one of the variables with a significant adverse effect on survival. In addition, the significant difference in survival between the pN0 and pNx groups might indicate a therapeutic benefit of LN dissection, although removing more LNs did not uniformly increase the probability of CSS.

Entities:  

Mesh:

Year:  2008        PMID: 18410428     DOI: 10.1111/j.1464-410X.2008.07673.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

1.  [Comparison of efficacy and safety between two different methods of nephroureterectomy in two centers].

Authors:  J F Wu; R C Lin; Y C Lin; W H Cai; Q G Zhu; D Fang; G Y Xiong; L Zhang; L Q Zhou; L F Ye; X S Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

2.  Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.

Authors:  Piotr Zareba; Barak Rosenzweig; Andrew G Winer; Jonathan A Coleman
Journal:  Cancer       Date:  2017-02-02       Impact factor: 6.860

3.  Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.

Authors:  Junichi Inokuchi; Kentaro Kuroiwa; Yoshiyuki Kakehi; Mikio Sugimoto; Toshiki Tanigawa; Hiroyuki Fujimoto; Momokazu Gotoh; Naoya Masumori; Osamu Ogawa; Masatoshi Eto; Chikara Ohyama; Akito Yamaguchi; Hideyasu Matsuyama; Tomohiko Ichikawa; Tomohiko Asano; Junki Mizusawa; Junko Eba; Seiji Naito
Journal:  World J Urol       Date:  2017-05-15       Impact factor: 4.226

4.  Does multidetector computed tomographic urography (MDCTU) T staging classification correspond with pathologic T staging in upper tract urothelial carcinoma?

Authors:  Seong Hyeon Yu; Young Hoe Hur; Eu Chang Hwang; Myung Soo Kim; Ho Seok Chung; Byung Chan Lee; Suk Hee Heo; Chan Choi; Jun Eul Hwang; Woo Kyun Bae; Seung Il Jung; Dong Deuk Kwon
Journal:  Int Urol Nephrol       Date:  2020-08-28       Impact factor: 2.370

5.  Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).

Authors:  Meera R Chappidi; Max Kates; Michael H Johnson; Noah M Hahn; Trinity J Bivalacqua; Phillip M Pierorazio
Journal:  Urol Oncol       Date:  2016-07-27       Impact factor: 3.498

6.  Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.

Authors:  Marco Moschini; Beat Foerster; Mohammad Abufaraj; Francesco Soria; Thomas Seisen; Morgan Roupret; Pierre Colin; Alexandre De la Taille; Benoit Peyronnet; Karim Bensalah; Roman Herout; Manfred Peter Wirth; Vladimir Novotny; Piotr Chlosta; Marco Bandini; Francesco Montorsi; Giuseppe Simone; Michele Gallucci; Giuseppe Romeo; Kazumasa Matsumoto; Pierre Karakiewicz; Alberto Briganti; Shahrokh F Shariat
Journal:  World J Urol       Date:  2017-02-28       Impact factor: 4.226

Review 7.  The role of lymphadenectomy for upper tract urothelial carcinoma.

Authors:  Jamie Messer; Yu Kuan Lin; Jay D Raman
Journal:  Nat Rev Urol       Date:  2011-05-24       Impact factor: 14.432

Review 8.  Current role of lymphadenectomy in the upper tract urothelial carcinoma.

Authors:  Mario Alvarez-Maestro; Juan Gómez Rivas; Sergio Alonso Y Gregorio; Cristina de Castro Guerin; Ángel Tabernero Gómez; Jesús Cisneros Ledo
Journal:  Cent European J Urol       Date:  2016-11-30

9.  The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma.

Authors:  Christopher B Allard; Abdulaziz Alamri; Shawn Dason; Farough Farrokhyar; Edward D Matsumoto; Anil Kapoor
Journal:  World J Urol       Date:  2012-07-29       Impact factor: 4.226

Review 10.  Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Thomas Seisen; Shahrokh F Shariat; Olivier Cussenot; Benoit Peyronnet; Raphaële Renard-Penna; Pierre Colin; Morgan Rouprêt
Journal:  World J Urol       Date:  2016-01-25       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.